Global Bioimpedance Devices Market Size To Exceed USD 1320.8 Million By 2035 | CAGR of 6.65%
Category: HealthcareGlobal Bioimpedance Devices Market Size To Exceed USD 1320.8 Million By 2035
According to a research report published by Spherical Insights & Consulting, the Global Bioimpedance Devices Market Size is Expected to Grow from USD 650.5 Million in 2024 to USD 1320.8 Million by 2035, at a CAGR of 6.65% during the forecast period 2025-2035.
Get more details on this report -
Browse key industry insights spread across 240 pages with 121 Market data tables and figures & charts from the report on the "Global Bioimpedance Devices Market Size, Share, and COVID-19 Impact Analysis, By Product Type (Multi-Frequency, Single-Frequency, and Dual-Frequency), By End User (Specialty Clinics, Hospitals, Rehabilitation Centers, and Others), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2025 – 2035." Get Detailed Report Description Here : https://www.sphericalinsights.com/reports/bioimpedance-devices-market
The bioimpedance devices market includes the development, production, and distribution of medical devices that measure the electrical impedance of biological tissues on a global scale. These instruments are primarily employed for the non-invasive assessment of fluid balance, body composition, and physiological parameters. In the domains of nutrition, cardiology, nephrology, and oncology, they facilitate monitoring and diagnoses. The market for bioimpedance devices provides physicians with useful tools for tracking metabolic health and determining body composition, as well as enabling them to treat patients according to their unique needs. The market for bioimpedance devices is driven by a number of factors, including the need for non-invasive diagnostics, the rise in chronic illness rates, technological advancements, personalized healthcare trends, the use of remote monitoring, and the global awareness of preventive care in clinical, home, and wellness settings. The rising prevalence of chronic renal diseases worldwide is the main driver of the bioimpedance device industry. The change to remote patient monitoring, preventive care initiatives, and aging populations are propelling the market's growth. However, the market expansion for bioimpedance devices may be restricted by new wearable technology that allows users to continuously check physiological data.
The multi-frequency segment dominated the market in 2024 and is projected to grow at a substantial CAGR during the forecast period.
Based on the product type, the bioimpedance devices market is divided into multi-frequency, single-frequency, and dual-frequency. Among these, the multi-frequency segment dominated the market in 2024 and is projected to grow at a substantial CAGR during the forecast period. The need for reliable, multifrequency-enabled bioimpedance analysis is anticipated to increase significantly in clinical and athletic performance settings as data-driven diagnostics gain prominence.
The hospitals segment accounted for the largest share in 2024 and is anticipated to grow at a remarkable CAGR during the forecast period.
Based on the end user, the bioimpedance devices market is divided into specialty clinics, hospitals, rehabilitation centers, and others. Among these, the hospitals segment accounted for the largest share in 2024 and is anticipated to grow at a remarkable CAGR during the forecast period. The prevalence of chronic conditions, hospitalization trends is becoming more widespread. The hospitals are more widely distributed across both urban and rural regions.
North America is expected to hold the majority share of the global bioimpedance devices market during the forecast period.
Get more details on this report -
North America is expected to hold the majority share of the global bioimpedance devices market during the forecast period. The health care system in the United States of America is said to be very technologically savvy and adaptable. Due to obesity, a significant portion of Americans suffer from bronchial asthma. The United States provides a setting that makes it feasible to introduce and test cutting-edge medical gadgets, like bioimpedance technology.
Asia Pacific is anticipated to grow at the fastest pace in the global bioimpedance devices market during the forecast period. As countries like China, India, and Indonesia become more economically prosperous, the Asia-Pacific region's population is growing, the number of elderly people in China and Japan is increasing, people are becoming more interested in a western lifestyle, distribution channels have improved, and people are becoming more proactive about their health.
Major vendors in the global bioimpedance devices market are Akern, Soehnle, Biotekna, Bioparhom, EVOLT 360, RJL Systems, ImpediMed Ltd., Tanita Corporation, Omron Corporation, Maltron International, Fresenius Medical Care., Biodnamics Corporation, General Electric Company, Fook Tin Group Holding Ltd, and Others.
Target Audience
- Market Players
- Investors
- End-users
- Government Authorities
- Consulting and Research Firm
- Venture capitalists
- Value-Added Resellers (VARs)
Recent Development
- In January 2025, Researchers at Georgia Tech have announced the release of Arthroba, a wearable gadget that uses AI and bioimpedance to identify tissue damage and joint swelling. Through a linked smartphone app, the innovation facilitates real-time joint health tracking, preventive care, and customized rehabilitation.
Market Segment
This study forecasts revenue at global, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the bioimpedance devices market based on the below-mentioned segments:
Global Bioimpedance Devices Market, By Product Type
- Multi-Frequency
- Single-Frequency
- Dual-Frequency
Global Bioimpedance Devices Market, By End User
- Specialty Clinics
- Hospitals
- Rehabilitation Centers
- Others
Global Bioimpedance Devices Market, By Regional Analysis
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia Pacific
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- UAE
- Saudi Arabia
- Qatar
- South Africa
- Rest of the Middle East & Africa
About the Spherical Insights & Consulting
Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.
Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements.
CONTACT US:
For More Information on Your Target Market, Please Contact Us Below:
Phone: +1 303 800 4326 (the U.S.)
Phone: +91 90289 24100 (APAC)
Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com
Contact Us: https://www.sphericalinsights.com/contact-us
Need help to buy this report?